Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

511
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy-associated vascular complications and thoracic aortic growth patterns.

JTCVS structural and endovascular·2026
Same author

Transcatheter aortic valve replacement use in young patients before and after the first low-risk trial publication.

JTCVS structural and endovascular·2026
Same author

Design of a Conductive Hydrogel Coating to Improve Catheter-Tissue Coupling in Radiofrequency Ablation.

bioRxiv : the preprint server for biology·2026
Same author

Reconstructing 12-lead ECG from reduced lead sets using an encoder-decoder convolutional neural network.

Biomedical signal processing and control·2026
Same author

Robust magnetoelectric backscatter communication system for bioelectronic implants.

Communications engineering·2026
Same author

3D Microscale Mechanical Simulations of Hydrogel Coated Electrospun Meshes.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 2, 2025

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
10:28

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

Published on: June 7, 2015

17.3K

Injectable ionic hydrogel conductors: Advancing material design to transform cardiac pacing.

Gabriel J Rodriguez-Rivera1, Allison Post2, Mathews John2

  • 1McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, TX, 787212, USA.

Biomaterials
|January 14, 2025
PubMed
Summary

Researchers developed an injectable hydrogel electrode to pace heart tissue, potentially preventing ventricular arrhythmias and avoiding painful defibrillation. This novel electrode navigates coronary veins, offering a less invasive treatment for cardiac conditions.

Keywords:
ArrhythmiasBiomaterialsConductiveHydrogelsInjectablePacing

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.4K
Fabrication of Myogenic Engineered Tissue Constructs
13:43

Fabrication of Myogenic Engineered Tissue Constructs

Published on: May 1, 2009

10.4K

Related Experiment Videos

Last Updated: Jun 2, 2025

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
10:28

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart

Published on: June 7, 2015

17.3K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.4K
Fabrication of Myogenic Engineered Tissue Constructs
13:43

Fabrication of Myogenic Engineered Tissue Constructs

Published on: May 1, 2009

10.4K

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Medical Devices

Background:

  • Ventricular arrhythmias are often caused by re-entry circuits in the mid-myocardium.
  • Current pacing methods struggle to reach these deep myocardial regions due to electrode size limitations.
  • Existing treatments like defibrillation and ablation can be painful and invasive.

Purpose of the Study:

  • To develop an injectable, conductive hydrogel electrode for pacing mid-myocardial tissue.
  • To overcome the limitations of current electrodes in accessing coronary veins.
  • To create a less invasive alternative to defibrillation and cardiac ablation.

Main Methods:

  • Developed a novel polyether urethane diacrylamide macromer hydrogel matching myocardial stiffness.
  • Imparted ionic conductivity to the hydrogel, achieving 2-3X native myocardial levels.
  • Utilized a double-barrel syringe with a mixing head for rapid in situ redox-initiated curing.
  • Evaluated hydrogel viscosity and cure rate in an ex vivo porcine model.
  • Demonstrated in vivo deployment and pacing efficacy in a porcine model.

Main Results:

  • The hydrogel electrode demonstrated conductivity comparable to native myocardium, retained post-implantation.
  • Stable electrical stimulation was achieved over multiple cycles and significant lengths of cardiac veins.
  • The injectable hydrogel successfully filled coronary veins in vivo, reaching deeper and more refined areas than current technology.
  • The hydrogel exhibited appropriate viscosity and cure rate for homogeneous deployment.

Conclusions:

  • The injectable ionic hydrogel electrode shows promise for pacing previously inaccessible mid-myocardial tissue.
  • This technology offers a potential pathway for painless defibrillation and improved treatment of ventricular arrhythmias.
  • The developed hydrogel material is stable, conductive, and suitable for minimally invasive cardiac interventions.